(Q38066728)

28 August 2017

1 reference

title

Designing a new antifungal glycoconjugate vaccine (English)

1 reference

28 August 2017

Margaret A Johnson

1

1 reference

PubMed ID

23232662

28 August 2017

David R Bundle

series ordinal

2

1 reference

28 August 2017

11 December 2012

1 reference

28 August 2017

Chemical Society Reviews

1 reference

28 August 2017

42

1 reference

28 August 2017

10

1 reference

28 August 2017

4327-4344

1 reference

Prospects for development of a vaccine to prevent and control vaginal candidiasis

28 August 2017

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

C. albicans colonization of human mucosal surfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Epidemiology of invasive candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Epidemiology of invasive candidiasis: a persistent public health problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Emerging Issues in Nosocomial Fungal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Defining criteria for anti-mannan antibodies to protect against candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

The epidemiology of meningococcal disease and the impact of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Prospects for vaccine prevention of meningococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

The changing and dynamic epidemiology of meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Structures of synthetic O-antigen fragments from serotype 2a Shigella flexneri in complex with a protective monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Doubly branched hexasaccharide epitope on the cell wall polysaccharide of group A streptococci recognized by human and rabbit antisera

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Saturation transfer difference 1D-TOCSY experiments to map the topography of oligosaccharides recognized by a monoclonal antibody directed against the cell-wall polysaccharide of group A streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Immunochemical characterization of polyclonal and monoclonal Streptococcus group A antibodies by chemically defined glycoconjugates and synthetic oligosaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Immunochemical studies of Shigella flexneri 2a and 6, and Shigella dysenteriae type 1 O-specific polysaccharide-core fragments and their protein conjugates as vaccine candidates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: Molecular basis for serotype specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Synthetic fragments of Vibrio cholerae O1 Inaba O-specific polysaccharide bound to a protein carrier are immunogenic in mice but do not induce protective antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Immunogenicity in a mouse model of a conjugate vaccine made with a synthetic single repeating unit of type 14 pneumococcal polysaccharide coupled to CRM197.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Molecular analysis of carbohydrate-antibody interactions: case study using a Bacillus anthracis tetrasaccharide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Beta-glucan-CRM197 conjugates as candidates antifungal vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Immunochemistry of pathogenic yeast, Candida species, focusing on mannan

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Candida albicans serotype B strains synthesize a serotype-specific phospholipomannan overexpressing a beta-1,2-linked mannotriose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Candida albicans phospholipomannan, a new member of the fungal mannose inositol phosphoceramide family

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Role of phospholipomannan in Candida albicans escape from macrophages and induction of cell apoptosis through regulation of bad phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Chemical structure of the cell-wall mannan of Candida albicans serotype A and its difference in yeast and hyphal forms

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

C. albicans increases cell wall mannoprotein, but not mannan, in response to blood, serum and cultivation at physiological temperature

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

New insights into the structure of (1→3,1→6)-β-D-glucan side chains in the Candida glabrata cell wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Identification of a new family of genes involved in beta-1,2-mannosylation of glycans in Pichia pastoris and Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Members 5 and 6 of the Candida albicans BMT family encode enzymes acting specifically on β-mannosylation of the phospholipomannan cell-wall glycosphingolipid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Synthesis of monodeoxy and mono-O-methyl congeners of methyl beta-D-mannopyranosyl-(1-->2)-beta-D-mannopyranoside for epitope mapping of anti-Candida albicans antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Design of a Candida albicans disaccharide conjugate vaccine by reverse engineering a protective monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Synthesis of three trisaccharide congeners to investigate frame shifting of β1,2-mannan homo-oligomers in an antibody binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Molecular recognition of Candida albicans (1->2)-β-mannan oligosaccharides by a protective monoclonal antibody reveals the immunodominance of internal saccharide residues

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Synthesis of a Candida albicans tetrasaccharide spanning the β1,2-mannan phosphodiester α-mannan junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Synthesis of glycoconjugate vaccines for Candida albicans using novel linker methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

A novel linker methodology for the synthesis of tailored conjugate vaccines composed of complex carbohydrate antigens and specific TH-cell peptide epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Boosting antibody responses by targeting antigens to dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

'Dressed for success' C-type lectin receptors for the delivery of glyco-vaccines to dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Robust immune responses elicited by a fully synthetic three-component vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Biologics through chemistry: total synthesis of a proposed dual-acting vaccine targeting ovarian cancer by orchestration of oligosaccharide and polypeptide domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Molecular phenotyping of mannosyltransferases-deficient Candida albicans cells by high-resolution magic angle spinning NMR

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

Induction of Protective Immunity by SyntheticVibrio choleraeHexasaccharide Derived fromV. choleraeO1 Ogawa Lipopolysaccharide Bound to a Protein Carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC2CS35382B

21 January 2018

Identifiers

DOI

10.1039/C2CS35382B

1 reference

28 August 2017

1 reference

PubMed ID

23232662